Literature DB >> 30922668

Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Alan S L Yu1, Chengli Shen2, Douglas P Landsittel2, Jared J Grantham3, Larry T Cook4, Vicente E Torres5, Arlene B Chapman6, Kyongtae Ty Bae7, Michal Mrug8, Peter C Harris5, Frederic F Rahbari-Oskoui9, Tiange Shi2, William M Bennett10.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by cyst and kidney growth, which is hypothesized to cause loss of functioning renal mass and eventually end-stage kidney disease. However, the time course of decline in glomerular filtration rate (GFR) is poorly defined. The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease study is a 14-year observational cohort study of 241 adults with ADPKD. As an estimate of the rate of kidney growth, participants were stratified into 5 subclasses based on baseline age and magnetic resonance imaging measurements of total kidney volume (TKV) according to the method of Irazabal. GFR trajectories spanning over four decades of life were reconstructed and fitted using mixed polynomial models, which were validated using data from the HALT-PKD study. GFR trajectories were nonlinear, with a period of relative stability in most participants, followed by accelerating decline. The shape and slope of these trajectories were strongly associated with baseline Irazabal class. Patients with PKD1 mutations had a steeper GFR decline than patients with PKD2 mutations or with no detected mutation, largely mediated by the effect of genotype on Irazabal class. Thus, GFR decline in ADPKD is nonlinear, and its trajectory throughout adulthood can be predicted from a single measurement of kidney volume. These models can be used for clinical prognostication, clinical trial design, and patient selection for clinical interventions. Our findings support a causal link between growth in kidney volume and GFR decline, adding support for the use of TKV as a surrogate endpoint in clinical trials.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADPKD; chronic kidney disease

Mesh:

Substances:

Year:  2019        PMID: 30922668      PMCID: PMC6478515          DOI: 10.1016/j.kint.2018.12.023

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  mTOR inhibitors in polycystic kidney disease.

Authors:  Terry Watnick; Gregory G Germino
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

Review 2.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

3.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

4.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

Review 5.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

6.  Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.

Authors:  María V Irazabal; Laureano J Rangel; Eric J Bergstralh; Sara L Osborn; Amber J Harmon; Jamie L Sundsbak; Kyongtae T Bae; Arlene B Chapman; Jared J Grantham; Michal Mrug; Marie C Hogan; Ziad M El-Zoghby; Peter C Harris; Bradley J Erickson; Bernard F King; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

7.  Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease.

Authors:  K T Bae; P K Commean; J Lee
Journal:  J Comput Assist Tomogr       Date:  2000 Jul-Aug       Impact factor: 1.826

8.  Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.

Authors:  Elizabeth Dicks; Pietro Ravani; Deanna Langman; William S Davidson; York Pei; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 8.237

9.  Rate of functional deterioration in polycystic kidney disease.

Authors:  K A Franz; F C Reubi
Journal:  Kidney Int       Date:  1983-03       Impact factor: 10.612

10.  Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Christina M Heyer; Jamie L Sundsbak; Kaleab Z Abebe; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Kyongtae T Bae; Robert W Schrier; Ronald D Perrone; William E Braun; Theodore I Steinman; Michal Mrug; Alan S L Yu; Godela Brosnahan; Katharina Hopp; Maria V Irazabal; William M Bennett; Michael F Flessner; Charity G Moore; Douglas Landsittel; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

View more
  21 in total

1.  The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

Authors:  Sravanthi Lavu; Lisa E Vaughan; Sarah R Senum; Timothy L Kline; Arlene B Chapman; Ronald D Perrone; Michal Mrug; William E Braun; Theodore I Steinman; Frederic F Rahbari-Oskoui; Godela M Brosnahan; Kyongtae T Bae; Douglas Landsittel; Fouad T Chebib; Alan Sl Yu; Vicente E Torres; Peter C Harris
Journal:  JCI Insight       Date:  2020-08-06

2.  Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.

Authors:  Jacob A Torres; Samantha L Kruger; Caroline Broderick; Tselmeg Amarlkhagva; Shagun Agrawal; John R Dodam; Michal Mrug; Leslie A Lyons; Thomas Weimbs
Journal:  Cell Metab       Date:  2019-10-17       Impact factor: 27.287

3.  Examining the Role of Novel CKD Therapies for the ADPKD Patient.

Authors:  Dipal M Patel; Neera K Dahl
Journal:  Kidney360       Date:  2021-03-24

4.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

5.  Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects.

Authors:  Sebastian Strubl; Simon Oehm; Jacob A Torres; Franziska Grundmann; Jazmine Haratani; Morgan Decker; Sabrina Vuong; Amrit Kaur Bhandal; Nils Methot; Rhianna Haynie-Cion; Franziska Meyer; Florian Siedek; Uwe Korst; Roman-Ulrich Müller; Thomas Weimbs
Journal:  Clin Kidney J       Date:  2021-09-13

6.  Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.

Authors:  Pedram Akbari; Fatemah Nasri; Shirley X Deng; Saima Khowaja; Seung H Lee; William Warnica; Hua Lu; Anand Rattansingh; Mostafa Atri; Korosh Khalili; Pei York
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-05       Impact factor: 10.614

7.  Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

Authors:  Judith E Heida; Ron T Gansevoort; A Lianne Messchendorp; Esther Meijer; Niek F Casteleijn; Wendy E Boertien; Debbie Zittema
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-27       Impact factor: 8.237

8.  The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.

Authors:  Bunyong Phakdeekitcharoen; Watcharapong Treesinchai; Pornphan Wibulpolprasert; Sarinya Boongird; Pinkael Klytrayong
Journal:  BMC Nephrol       Date:  2021-05-15       Impact factor: 2.388

9.  A Systematic Review of Renal Functional Reserve in Adult Living Kidney Donors.

Authors:  Andreja Figurek; Valerie A Luyckx; Thomas F Mueller
Journal:  Kidney Int Rep       Date:  2020-01-20

10.  Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.

Authors:  Shosha E I Dekker; Aswin Verhoeven; Darius Soonawala; Dorien J M Peters; Johan W de Fijter; Oleg A Mayboroda
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.